AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (6.6 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access

The roles of cell cycle proteins in regulating the tumor immune microenvironment

Qingbo ZhuXiaoli WeiZiting QuLili LuYiyin Zhang( )Hua Wang( )
Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China

Peer review under responsibility of Chongqing Medical University.

Show Author Information

Abstract

Recent studies have shown that in addition to regulating the growth of tumor cells, cell cycle proteins can also regulate immune cells and factors in the tumor immune microenvironment (TIME), thus playing a role in regulating tumor immunity. This review summarizes the relevant mechanisms of cell cycle regulatory proteins in TIME regulation. The development of effective drugs against relevant therapeutic targets may be a hot research topic for the next generation of antitumor immunotherapy.

References

【1】
【1】
 
 
Genes & Diseases

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhu Q, Wei X, Qu Z, et al. The roles of cell cycle proteins in regulating the tumor immune microenvironment. Genes & Diseases, 2026, 13(1). https://doi.org/10.1016/j.gendis.2025.101706

247

Views

1

Downloads

5

Crossref

6

Web of Science

4

Scopus

0

CSCD

Received: 10 August 2024
Revised: 04 March 2025
Accepted: 23 April 2025
Published: 04 June 2025
© 2025 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).